Benaloun E, Sermondade N, Moreau E, Chabbert-Buffet N, Cristofari S, Johnson N, Lévy R, Dupont C
Service de biologie de la reproduction CECOS, AP-HP, hôpital Tenon, Paris, France.
Service de biologie de la reproduction-CECOS, AP-HP, hôpital Tenon, Sorbonne université, Saint-Antoine Research centre, Inserm équipe lipodystrophies génétiques et acquises, Paris, France.
Gynecol Obstet Fertil Senol. 2021 Jun;49(6):547-552. doi: 10.1016/j.gofs.2021.01.007. Epub 2021 Jan 9.
The evolution of medical care for transgender people currently makes it possible to propose fertility preservation. Fertility preservation should be initiated before the start of hormonal treatments and/or surgical procedures. The "reproductive" aspect and the desire for parenthood among transgender people have long been ignored. However, these aspects are important to consider and fertility preservation should be discussed before the start of the physical transition. The aim of this review is to assess the literature on fertility preservation for transgender women ("male to female"). Many uncertainties remain regarding the impact of hormonal treatments on the reproductive functions of transgender women and their reversibility. However, the significant increase in the number of recently published articles is evidence of the improvement in the conditions of access to these procedures for women starting a transition process. Nevertheless, there are still a number of barriers that can prevent or delay this process.
目前，针对跨性别者的医疗护理发展使得提出生育力保存成为可能。生育力保存应在激素治疗和/或外科手术开始之前启动。长期以来，跨性别者的“生殖”方面以及为人父母的愿望一直被忽视。然而，这些方面很重要，值得考虑，并且在开始身体转变之前就应该讨论生育力保存问题。本综述的目的是评估关于跨性别女性（“男变女”）生育力保存的文献。关于激素治疗对跨性别女性生殖功能的影响及其可逆性仍存在许多不确定性。然而，最近发表的文章数量显著增加，这证明了开始转变过程的女性获得这些程序的条件有所改善。尽管如此，仍然存在一些障碍可能会阻止或延迟这一过程。
